» Authors » Sang-Yeon Kan

Sang-Yeon Kan

Explore the profile of Sang-Yeon Kan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 133
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim G, Kan S, Kang H, Lee S, Ko H, Kim J, et al.
Int J Mol Sci . 2019 Sep; 20(19). PMID: 31561416
Abnormally upregulated cholesterol and lipid metabolism, observed commonly in multiple cancer types, contributes to cancer development and progression through the activation of oncogenic growth signaling pathways. Although accumulating evidence has...
2.
Kang H, Oh T, Bahk Y, Kim G, Kan S, Shin D, et al.
Cancers (Basel) . 2019 Sep; 11(9). PMID: 31540279
Heat shock factor 1 (HSF1) is an essential transcription factor in cellular adaptation to various stresses such as heat, proteotoxic stress, metabolic stress, reactive oxygen species, and heavy metals. HSF1...
3.
Kim G, Choi S, Oh T, Kan S, Kang H, Lee S, et al.
Int J Mol Sci . 2019 Jun; 20(11). PMID: 31151327
The R132H mutation in isocitrate dehydrogenase 1 (IDH1) is commonly observed and associated with better survival in glioblastoma multiforme (GBM), a malignant brain tumor. However, the functional role of IDH1...
4.
Lee Y, Kim G, Park E, Oh T, Lee S, Kan S, et al.
Int J Mol Sci . 2019 Mar; 20(5). PMID: 30832444
Several reports have shown that thymoquinone (TQ) effectively attenuates angiogenesis in cancer cells, resulting in suppression of tumor growth. However, it is not yet clear whether TQ reduces hypoxia-inducible factor-1α...
5.
Oh T, Jung H, Lee Y, Lee S, Kim G, Kan S, et al.
Int J Mol Sci . 2018 Oct; 19(10). PMID: 30322121
Zerumbone (ZER), an active constituent of the Zingiberaceae family, has been shown to exhibit several biological activities, such as anti-inflammatory, anti-allergic, anti-microbial, and anti-cancer; however, it has not been studied...
6.
Kim Y, Lee Y, Oh T, Shin D, Kim G, Kan S, et al.
Int J Mol Sci . 2018 Oct; 19(10). PMID: 30321984
Reduced therapeutic efficacy of sorafenib, a first-generation multikinase inhibitor, is often observed during the treatment of advanced hepatocellular carcinoma (HCC). Emodin is an active component of Chinese herbs, and is...